Departamento de Fisiología, Facultad de Farmacia, Universidad Complutense, Madrid, Spain.
J Sex Med. 2014 Jun;11(6):1463-74. doi: 10.1111/jsm.12526. Epub 2014 Apr 4.
Endothelin 1 (ET-1) levels and receptors are up-regulated in the erectile tissue of diabetic patients and animal models of erectile dysfunction (ED).
The present study assessed the role of ET-1 receptors in the impaired adrenergic vasoconstriction and nitrergic relaxation of penile arteries from a rat model of insulin resistance.
The effect of ET receptor antagonists was evaluated on the contractile responses to electrical field stimulation (EFS) of penile arteries from obese Zucker rats (OZRs) compared with lean Zucker rats (LZRs). ET receptor expression was determined by immunohistochemistry.
Changes in neural nitrergic relaxation and adrenergic vasoconstriction and the expression of ET receptors in perivascular nerves were assessed.
ET-1 (10(-10) M) enhanced EFS-induced vasoconstriction, and treatment with the adrenergic neurotoxin guanethidine reduced the contractions induced by ET-1 in penile arteries from both LZRs and OZRs, thus supporting the hypothesis that ET-1 releases noradrenaline from adrenergic nerves. ET-1 antagonized neural nitric oxide (NO)-mediated relaxant responses in LZR arteries, antagonizing relaxations induced by the NO donor S-nitroso-N-acetylpenicillamine to a larger extent in arteries from OZRs. ET(A) and ET(B) receptors were expressed in perivascular fibers colocalized with the neuronal marker protein gene product 9.5 in penile arteries from OZRs. The ET(A) receptor antagonist BQ-123 reversed the enhancing effect of ET-1 on the vasoconstriction elicited by EFS and the ET-1-induced inhibition of nitrergic relaxations in LZRs, restoring them to control levels in penile arteries of OZRs.
ET-1 enhances adrenergic vasoconstriction through presynaptic ET(A) receptors and antagonizes neural NO-mediated relaxation through postsynaptic smooth muscle ET(A) receptors in penile arteries from OZRs, which likely contributes to the augmented vasoconstriction and blunted nitrergic relaxation of erectile tissue under conditions of insulin resistance.
内皮素 1(ET-1)水平和受体在糖尿病患者和勃起功能障碍(ED)动物模型的勃起组织中上调。
本研究评估了 ET-1 受体在胰岛素抵抗大鼠模型阴茎动脉去甲肾上腺素能血管收缩和硝酸酯松弛受损中的作用。
通过免疫组织化学法测定肥胖 Zucker 大鼠(OZRs)与 lean Zucker 大鼠(LZRs)阴茎动脉对电刺激(EFS)的收缩反应,评估 ET 受体拮抗剂的作用。
评估神经型硝酸酯松弛和去甲肾上腺素能血管收缩的变化以及血管周围神经中 ET 受体的表达。
ET-1(10(-10)M)增强 EFS 诱导的血管收缩,而肾上腺素能神经毒素胍乙啶处理可降低阴茎动脉中 ET-1 诱导的收缩,从而支持 ET-1 从肾上腺素能神经释放去甲肾上腺素的假说。ET-1 拮抗 LZR 动脉中的神经型一氧化氮(NO)介导的松弛反应,在 OZRs 动脉中,NO 供体 S-亚硝基-N-乙酰青霉胺诱导的松弛反应拮抗作用更大。ET(A)和 ET(B)受体在 OZRs 阴茎动脉的血管周围纤维中表达,与神经元标记蛋白基因产物 9.5 共定位。ET(A)受体拮抗剂 BQ-123 逆转了 ET-1 对 EFS 引起的血管收缩的增强作用,以及 ET-1 对 LZRs 中硝酸酯松弛的抑制作用,使其恢复到 OZRs 阴茎动脉的对照水平。
ET-1 通过突触前 ET(A)受体增强去甲肾上腺素能血管收缩,并通过突触后平滑肌 ET(A)受体拮抗神经型 NO 介导的松弛作用,这可能导致胰岛素抵抗条件下勃起组织的血管收缩增强和硝酸酯松弛减弱。